Tilray Brands, Inc. SEC filings TLRY
Tilray Brands, Inc. has 770 filings in SEC EDGAR's recent list, going back to Feb 20, 2018. Its latest annual report, Form ARS, was filed on Sep 28, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 8, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (results of operations). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Mar 18, 2026 | — |
| CORRESP | Letter to the SEC | Mar 13, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2026 | — |
| CORRESP | Letter to the SEC | Feb 27, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2026 | — |
| 305B2 | Filing | May 26, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2021 | — |
| CORRESP | Letter to the SEC | Mar 12, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2021 | — |
| 425 | Form 8-k | Dec 21, 2020 | — |
| 425 | Filing | Dec 17, 2020 | — |
| 425 | Filing | Dec 16, 2020 | — |
| 425 | Filing | Dec 16, 2020 | — |
| 425 | Form 8-k | Dec 16, 2020 | — |
| 8-A12B/A | Filing | Oct 1, 2020 | — |
| 425 | Form 8-k | Dec 17, 2019 | — |
| 425 | Filing | Nov 13, 2019 | — |
| EFFECT | Filing | Nov 12, 2019 | — |
| CORRESP | Letter to the SEC | Nov 8, 2019 | — |
| CORRESP | Letter to the SEC | Nov 8, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2019 | — |
| 425 | 8-k | Sep 10, 2019 | — |
| 425 | 8-k | Sep 10, 2019 | — |
| 425 | 8-k downstream merger | Jun 11, 2019 | — |
| CT ORDER | Filing | Apr 1, 2019 | — |
| EFFECT | Filing | Jul 18, 2018 | — |
| CERT | Filing | Jul 18, 2018 | — |
| CORRESP | Letter to the SEC | Jul 16, 2018 | — |
| CORRESP | Letter to the SEC | Jul 16, 2018 | — |
| 8-A12B | Form 8-a12b | Jul 16, 2018 | — |
| CORRESP | Letter to the SEC | Jul 9, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2018 | — |
| CORRESP | Letter to the SEC | Jun 20, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2018 | — |
| DRSLTR | Filing | May 30, 2018 | — |
| DRS/A | Filing | May 30, 2018 | — |
| UPLOAD | Letter from the SEC | May 18, 2018 | — |
| DRSLTR | Filing | May 2, 2018 | — |
| DRS/A | Filing | May 2, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2018 | — |
| DRS | Filing | Mar 19, 2018 | — |
| D | Filing | Feb 20, 2018 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- TLRY (Nasdaq)
- Fiscal year ends
- May 31
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1731348
- Former names
- Tilray, Inc. (until Jan 10, 2022)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.